Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quest molecule, KANAb 001, represents a promising treatment focused on PD-1. First medical results from these programs, KANAb 001 and E-6011, demonstrate positive https://www.targetmol.com/compound/quetmolimab